Certara to Participate in the Barclays Global Healthcare Conference

PRINCETON, N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the Barclays Global Healthcare Conference.

Company management will present at 11:15AM ET on Wednesday, March 15th, 2023.

A live webcast of the event will be available on Certara’s investor relations website at https://ir.certara.com and will be available for replay for at least 90 days thereafter.

About CertaraCertara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,000 biopharmaceutical companies, academic institutions and regulatory agencies across 62 countries.

Investor Relations Contact:David DeuchlerGilmartin Group[email protected]

Media Contact:Daniel YungerKekst CNC[email protected]

You May Also Be Interested In

• Form 8.3 -DCC plc
• Confirmation of Adjournment Of Scheme Meetings And Extraordinary General Meeting
• AM Best Revises Issuer Credit Rating Outlook to Positive for Skyward Specialty Insurance Group’s Members